Chimeric gene delivery systems

Pharmaceutical Gene Delivery Systems

Volumn , Issue , 2003, Pages 137-148

  Kaneda, Yasufumi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906588381     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (37)

1. Marshall E. Gene therapy’s growing pains. Science 1995; 269:1052-1055.
2. Mulligan RC. The basic science of gene therapy. Science 1993; 260:926-932.
3. Ledley F D. Non-viral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 1995; 6:1129-1144.
4. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90:8033-8037.
5. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage F, Verma I, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentivirus vector. Science 1996; 272:263-267.
6. Weinberg JB, Matthews TJ, Cullen BR, Malim MH. Productive human immunodeficiency virus type 1 (HIV-1) infection of non-proliferating human monocytes. J Exp Med 1991; 174:1477-1482.
7. Martin FJ, Papahadjopoulos D. Irreversible coupling of immunoglobulin fragments to preformed vesicles. J Biol Chem 1982; 257:286-288.
8. Leserman LD, Barbet J, Kourilsky, F. Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A. Nature 1980; 288:602-604.
9. Mizuno M, Yoshida J, Sugita K, Inoue I, Seo H, Hayashi Y, Koshizaka T, Yagi K. Growth inhibition of glioma cells tranfected with human beta-interferon gene by liposomes coupled with a monoclonal antibody. Cancer Res 1990; 50:7826-7829.
10. Machy P, Lewis F, McMillan L, Jonak, ZL. Gene transfer from targeted liposomes to specific lymphoid cells by electroporation. Proc Natl Acad Sci USA 1988; 85: 8027-8031.
11. Wu GY, Wu CH. Receptor-mediated gene delivery and expression in vivo. J Biol Chem 1988; 263:14621-14624.
12. Zenke M, Steinlein P, Wagner E, Cotten M, Beug H, Birnstiel, ML. Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells. Proc Natl Acad Sci USA 1990; 87:3655-3659.
13. Kaneda Y. Fusigenic Sendai-virus liposomes: a novel hybrid type liposome for gene therapy. Biogenic Amines 1998; 14:553-572.
14. Kaneda Y, Saeki Y, Morishita R. Gene therapy using HVJ-liposomes; the best of both worlds. Mol Med Today 1999; 5:298-303.
15. Schoen P, Chonn A, Cullis PR, Wilschut J, Scherrer P. Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles. Gene Ther 1999; 6: 823-832.
16. Schreier H, Mora P, Caras IW. Targeting liposomes to cells expressing CD4 using glycosylphosphatidylinositol-anchored gp120. Influence of liposome composition on intracellular trafficking. J Biol Chem 1994; 269:9090-9098.
17. Okada Y. Sendai-virus induced cell fusion. In: Duzgunes N, ed. Methods in Enzy-mology. Vol 221. San Diego: Academic Press, 1993: 18-41.
18. Hirano T, Fujimoto J, Ueki T, Yamamoto H, Iwasaki T, Morishita R, Sawa Y, Kaneda Y, Takahashi H, Okamoto E. Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome. Gene Ther 1998; 5:459-464.
19. Suzuki K, Nakashima H, Sawa Y, Morishita R, Matsuda H, Kaneda Y. Reconstituted fusion liposomes for gene transfer in vitro and in vivo. Gene Ther Reg 2000; 1:65-77.
20. Uchida T, Kim, J, Yamaizumi M, Miyake Y, Okada Y. Reconstitution of lipid vesicles associated with HVJ (Sendai virus) spikes: purification and some properties of vesicles containing nontoxic fragment A of diphtheria toxin. J Cell Biol 1979; 80: 10-20.
21. Saeki Y, Matsumoto N, Nakano Y, Mori M, Awai K, Kaneda Y. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Hum Gene Ther 1997; 8:1965-1972.
22. Chander R, Schreier H. Artificial viral envelopes containing recombinant human immunodeficiency virus (HIV) gp160. Life Sci 1992; 50:481-489.
23. Sawa Y, Kaneda Y, H-Z Bai, Suzuki K, Fujimoto J, Morishita R, Matsuda H. Efficient transfer of oligonucleotides and plasmid DNA into the whole heart through the coronary artery. Gene Ther 1998; 5:1472-1480.
24. Goyal K, Huang L. Gene therapy using DC-Chol liposomes. J Liposome Res 1995; 5:49-60.
25. Yamada G, Nakamura S, Haraguchi R, Sakai M, Terashi T, Sakisaka S, Toyoda T, Ogino Y, Hatanaka H, Kaneda Y. An efficient liposome-mediated gene transfer into the branchial arch, neural tube and the heart of chick embryos: a strategy to elucidate organogenesis. Cell Mol Biol 1997; 43:1165-1169.
26. Yonemitsu Y, Kaneda Y, Muraishi A, Yoshizumi T, Sugimachi K, Sueishi K. HVJ (Sendai virus)-cationic liposomes: a novel and potentially effective liposome-mediated gene transfer technique to the delivery to the airway epithelium. Gene Ther 1997; 4:631-638.
27. Kaneda Y, Iwai K, Uchida T. Introduction and expression of the human insulin gene in adult rat liver, J Biol Chem 1989; 264:12126-12129.
28. Yamano T, Ura K, Morishita R, Nakajima H, Monden M, Kaneda Y. Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deace-tylase. Mol Ther 2000; 1:425-431.
29. Lindahl T, Adams A, Bjursell G, Bomkamm GW, Kaschka-Dierich C, Jehn U. Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J Mol Biol 1976; 102:511-530.
30. Lupton S, Levine A J. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus derived plasmids in human cells, Mol Cell Biol 1985; 5:2533-2542.
31. Yates JL, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985; 313:812-815.
32. Kelleher ZT, Fu H, Elizabeth L, Wendelburg, B, Gulino, S, Vos J-M. Epstein-Barr-based episomal chromosomes shuttle 100 kb of self-replicating circular human DNA in mouse cells. Nat Biotechnol 1988; 16:762-768.
33. Wendelburg BJ, Vos J-M. An enhanced EBNA-1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells. Gene Ther 1998; 5:1389-1399.
34. Saeki Y, Wataya-Kaneda M, Tanaka K, Kaneda Y. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ-liposomes. Gene Ther 1998; 5:1031-1037.
35. Jankelevich S, Kolman JL, Bodnar JW, Miller G. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain. eMbO j 1992; 11:1165-1176.
36. Wysokenski DA, Yates JL. Multiple EBNA-1 binding sites are required to form an EBNA-1-dependent enhancer and to activate a minimal replication origin within oriP of Epstein-Barr virus. J Virol 1989; 63:2657-2666.
37. Kaneda Y, Saeki Y, Nakabayashi M, Zhou W-Z, Wataya-Kaneda M, Morishita, R. Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector. Hum Gene Ther 2000; 11:471-479.